Table II.
Subclass analysis of overall and disease-free survival.
| Variable | Overall survival | Disease-free survival |
|---|---|---|
| Age | ||
| <60 | 0.805 | 0.559 |
| ≥60 | 0.973 | 0.631 |
| Gender | ||
| Male | 0.579 | 0.225 |
| Female | 0.367 | 0.976 |
| HBs-Ag | ||
| (−) | 0.722 | 0.884 |
| (+) | 0.899 | 0.176 |
| HCV-Ab | ||
| (−) | 0.691 | 0.903 |
| (+) | 0.703 | 0.993 |
| Child-Pugh grade | ||
| A | 0.710 | 0.250 |
| B | 0.395 | 0.758 |
| CLIP score | ||
| 0 | 0.506 | 0.226 |
| 1–2 | 0.699 | 0.916 |
| 3–6 | 0.829 | 0.252 |
| AFP | ||
| <5 ng/ml | 0.112 | 0.994 |
| ≥5 ng/ml | 0.358 | 0.421 |
| PIVKA-II | ||
| <40 mAU/l | 0.633 | 0.353 |
| ≥40 mAU/l | 0.587 | 0.458 |
| Tumor size | ||
| <5 cm | 0.630 | 0.682 |
| ≥5 cm | 0.702 | 0.040 |
| Tumor number | ||
| Single | 0.334 | 0.176 |
| Multiple | 0.711 | 0.761 |
| Portal vein invasion | ||
| (−) | 0.873 | 0.421 |
| (+) | 0.520 | 0.344 |
| Intrahepatic metastasis | ||
| (−) | 0.550 | 0.239 |
| (+) | 0.524 | 0.257 |
| TNM stage | ||
| I | 0.523 | 0.925 |
| II | 0.771 | 0.625 |
| III | 0.645 | 0.326 |
| IV-A | 0.191 | 0.260 |